Showing results (1581-1590 of 2,133) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|April 17, 2001
Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzime and Zinnat) in healthy human volunteersM S Al-Said, K I Al-Khamis, E M Niazy, et al.Biopharmaceutics & Drug Disposition|November 5, 2002
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discoveryJ Cory Kalvass, Tristan S MaurerBiopharmaceutics & Drug Disposition|March 4, 2000
Pharmacokinetics of 9alpha-fluoromedroxyprogesterone acetate in rats: comparison with medroxyprogesterone acetateD Kozutsumi, A Kawashima, T Sugimoto, et al.Biopharmaceutics & Drug Disposition|December 18, 2001
In vitro protein binding studies with BMS-204352: lack of protein binding displacement interaction in human serumR Krishna, M Yao, D Kaczor, et al.Biopharmaceutics & Drug Disposition|December 18, 2001
The pharmacokinetics of ethosuximide enantiomers in the ratJ Mifsud, P S Collier, J S MillershipBiopharmaceutics & Drug Disposition|December 18, 2001
Linezolid absolute bioavailability and the effect of food on oral bioavailabilityI R Welshman, T A Sisson, G L Jungbluth, et al.Biopharmaceutics & Drug Disposition|December 18, 2001
Evaluation of a limited sampling method used to determine the bioequivalence of highly variable drugs with long half-livesA J JacksonBiopharmaceutics & Drug Disposition|December 18, 2001
Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patientsC U Pfister, A Martoni, C Zamagni, et al.Biopharmaceutics & Drug Disposition|December 18, 2001
Pharmacokinetics and tissue distribution of the anticholinergics tiotropium and ipratropium in the rat and dogA Leusch, B Eichhorn, G Müller, et al.Biopharmaceutics & Drug Disposition|December 26, 2001
Nonlinear pharmacokinetics of TAK-044, a new endothelin antagonist, in ratsT Takeuchi, Y Tagawa, K Hagihara, et al.Pageof 214